Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Electroacupuncture vs PTNS for women with refractory overactive bladder

Official title: Electroacupuncture as a Treatment for Refractory Overactive Bladder: A Feasibility /Pilot Randomized Controlled Trial

Run by Chelsea and Westminster NHS Foundation Trust · NCT07124390 · Data updated 2026-11-12

This study tests whether electroacupuncture or percutaneous tibial nerve stimulation can help women whose overactive bladder hasn’t improved with standard therapy.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment24 (estimated)
SponsorChelsea and Westminster NHS Foundation Trust
Academic / other
Locations1 site (London, United Kingdom)
StatusRecruiting
StartedAugust 15, 2026
Main results expectedNovember 30, 2027
Study endsDecember 30, 2027
Registry record updatedAugust 28, 2026
Trial IDNCT07124390 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older with overactive bladder refractory to first-line treatments and ICIQ-OAB score ≥10.

Probably not a fit

Individuals with pregnancy, active infection, severe needle phobia, a pacemaker, active cancer, or other exclusion criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-site feasibility randomized trial comparing electroacupuncture (EA) with PTNS in women with refractory overactive bladder. Twenty-four participants will be randomized to receive either EA or PTNS over 12 weeks, with follow-up at 6 weeks, 12 weeks, 6 months, and 12 months. The aim is to determine if a larger definitive trial is feasible by examining recruitment, retention, adherence, data completeness, safety, and participant acceptability, to inform future study design. The study sits within a pelvic health physiotherapy service and explores non-pharmacological treatment options for OAB. Outcomes will help clarify whether EA and PTNS merit direct comparison in a larger trial.

Why it matters

Potential benefit: If successful, the trial could support non-drug options for reducing OAB symptoms and improving quality of life.

How similar studies have gone: Prior work suggests neuromodulation approaches can help OAB, but direct comparison between EA and PTNS in this setting is novel and feasibility-focused.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Participants must meet all of the following criteria:

* Female adults aged 18 years or older.
* Diagnosed with overactive bladder syndrome (ICIQ-OAB score ≥10).
* Symptoms present for at least three months and refractory to first-line treatments.
* Willing to refrain from starting new bladder-related treatments during the study period.
* Able and willing to provide written informed consent.

Exclusion Criteria:

* Participants meeting any of the following criteria will be excluded:

  * Pregnant or planning pregnancy during the study period.
  * Bleeding disorders.
  * Severe needle phobia.
  * Presence of a pacemaker.
  * Active cancer diagnosis.
  * Active urinary tract infections or other urological conditions requiring urgent intervention.
  * Participation in another clinical trial for bladder dysfunction within the past six months.
  * Neurological conditions affecting continence (e.g., diabetic neuropathy, multiple sclerosis, Parkinson's disease).
  * Life-threatening infections.
  * Severe cognitive deficits, unconsciousness, dementia (e.g., Alzheimer's or other neurodegenerative diseases).
  * History of incontinence surgery.
  * Previous acupuncture for OAB within the past two months.
  * History of thromboses.
  * Recovering from or suffering from a serious illness or major surgery.

Where it's running

  • Chelsea and Westminster hospital NHS foundation Trust
    London, United Kingdom, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: Elmas X Court — Chelsea and Westminster Hospital and Imperial College London
  • Study coordinator: Elmas Court
  • Email: elmas.court@nhs.net
  • Phone: +447538355975

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.